Olga Sakharova, MD
Assistant Professor of MedicineDownloadHi-Res Photo
Cards
Appointments
Endocrinology
Primary
Contact Info
Endocrinology
PO Box 208020
New Haven, CT 06520-8020
United States
About
Titles
Assistant Professor of Medicine
Appointments
Endocrinology
Assistant ProfessorPrimary
Other Departments & Organizations
Education & Training
- Endocrinology Fellowship
- Yale University School of Medicine (2006), New Haven, CT (2006)
- Residency in Internal Medicine
- Hospital of Saint Raphael (2004), New Haven, CT (2004)
- Research Fellowship
- Brigham and Women’s Hospital (2001), Boston, MA (2001)
- Endocrinology Fellowship
- St. Petersburg State Pavlov Medical University (1996), St. Petersburg, Russia (1996)
- Residency in Internal Medicine
- St. Petersburg State Pavlov Medical University (1994), St. Petersburg, Russia (1994)
- MD
- Pavlov First State Medical University of St. Petersburg (1993)
Research
Overview
Medical Subject Headings (MeSH)
Endocrinology
Research at a Glance
Yale Co-Authors
Frequent collaborators of Olga Sakharova's published research.
Publications Timeline
A big-picture view of Olga Sakharova's research output by year.
James Dziura, MPH, PhD
Mark Schoenfeld, MD
7Publications
249Citations
Publications
2012
Effects on post-prandial glucose and AGE precursors from two initial insulin strategies in patients with Type 2 diabetes uncontrolled by oral agents
Sakharova OV, Lleva RR, Dziura JD, Spollett GR, Howell SK, Beisswenger PJ, Inzucchi SE. Effects on post-prandial glucose and AGE precursors from two initial insulin strategies in patients with Type 2 diabetes uncontrolled by oral agents. Journal Of Diabetes And Its Complications 2012, 26: 333-338. PMID: 22541894, DOI: 10.1016/j.jdiacomp.2012.03.027.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAdministration, OralAgedBlood GlucoseBody WeightCross-Over StudiesDiabetes Mellitus, Type 2FastingFemaleGlycated HemoglobinGlycation End Products, AdvancedHumansHypoglycemic AgentsInsulin GlargineInsulin LisproInsulin, Long-ActingMaleMiddle AgedPostprandial PeriodTreatment FailureTreatment OutcomeConceptsOral anti-hyperglycemic drugsPost-prandial glucoseInsulin strategiesFree fatty acidsType 2Post-prandial glucose metabolismProgressive β-cell dysfunctionType 2 diabetes patientsPost-prandial glucose levelsDaily insulin glargineInitial insulin regimenPrecursor of AGEsSingle-center studyClinical Research CenterLong-term diabetic complicationsAnti-hyperglycemic drugsType 2 diabetesΒ-cell dysfunctionCross-over designInitial insulinInsulin regimenOral agentsInsulin regimensInsulin therapyOAD therapy
2008
Cyclic Rapid Fluctuation of Hypertension and Hypotension in Pheochromocytoma
Ionescu CN, Sakharova OV, Harwood MD, Caracciolo EA, Schoenfeld MH, Donohue TJ. Cyclic Rapid Fluctuation of Hypertension and Hypotension in Pheochromocytoma. Journal Of Clinical Hypertension 2008, 10: 936-940. PMID: 19120720, PMCID: PMC8673043, DOI: 10.1111/j.1751-7176.2008.00046.x.Peer-Reviewed Original ResearchCitations
2007
Endocrine Assessments During Critical Illness
Sakharova OV, Inzucchi SE. Endocrine Assessments During Critical Illness. Critical Care Clinics 2007, 23: 467-490. PMID: 17900481, DOI: 10.1016/j.ccc.2007.05.007.Peer-Reviewed Original ResearchCitationsMeSH Keywords and Concepts
2006
"Glucometrics"--assessing the quality of inpatient glucose management.
Goldberg PA, Bozzo JE, Thomas PG, Mesmer MM, Sakharova OV, Radford MJ, Inzucchi SE. "Glucometrics"--assessing the quality of inpatient glucose management. Diabetes Technology & Therapeutics 2006, 8: 560-9. PMID: 17037970, DOI: 10.1089/dia.2006.8.560.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsInpatient glycemic controlGlycemic controlBG levelsGlucose managementGlucose levelsVenous plasma glucose levelsOutpatient glycemic controlStrict glycemic controlGeneral hospital wardsGold standardPlasma glucose levelsVenous glucose levelsBlood glucose managementInpatient glucose managementPatient care unitsQuality improvement initiativesIntensive care unit dataMedian BG levelHospitalized patientsCare unitIll patientsBlood samplesHospital wardsEvent ratesPatients
2005
Treatment of diabetes in the elderly
Sakharova OV, Inzucchi SE. Treatment of diabetes in the elderly. Postgraduate Medicine 2005, 118: 19-29. PMID: 16329527, DOI: 10.3810/pgm.2005.11.1684.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsMajor public health concernType 2 diabetesOverview of therapiesHost of comorbiditiesTreatment of diabetesPublic health concernEvidence-based informationAntidiabetic agentsTherapeutic goalsDiabetes treatmentDiabetesOlder populationHealth concernOlder adultsPrevalent formTreatmentMedical picturesComorbiditiesTherapy
2004
Improving glycemic control in the cardiothoracic intensive care unit: Clinical experience in two hospital settings
Goldberg PA, Sakharova OV, Barrett PW, Falko LN, Roussel MG, Bak L, Blake-Holmes D, Marieb NJ, Inzucchi SE. Improving glycemic control in the cardiothoracic intensive care unit: Clinical experience in two hospital settings. Journal Of Cardiothoracic And Vascular Anesthesia 2004, 18: 690-697. PMID: 15650975, DOI: 10.1053/j.jvca.2004.08.003.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsMeSH KeywordsAgedBlood GlucoseCardiac Surgical ProceduresCohort StudiesDrug MonitoringFemaleHospitals, CommunityHospitals, TeachingHumansHyperglycemiaHypoglycemic AgentsInfusions, IntravenousInsulinInsulin Infusion SystemsIntensive Care UnitsMalePostoperative ComplicationsProspective StudiesTime FactorsTreatment OutcomeConceptsIntensive insulin infusion protocolCardiothoracic intensive care unitIntensive care unitGlycemic controlBG levelsCare unitBG valuesCTICU patientsPerioperative glycemic controlRelevant baseline variablesTarget BG levelProspective cohort studyStrict glycemic controlTertiary referral hospitalAdverse clinical eventsInsulin infusion protocolCommunity teaching hospitalBlood glucose levelsNarrow target rangeCohort studyHospital chartsReferral hospitalClinical outcomesMedian timeClinical events
2001
Vasopeptidase inhibition affords greater renoprotection than angiotensin-converting enzyme inhibition alone.
Taal MW, Nenov VD, Wong W, Satyal SR, Sakharova O, Choi JH, Troy JL, Brenner BM. Vasopeptidase inhibition affords greater renoprotection than angiotensin-converting enzyme inhibition alone. Journal Of The American Society Of Nephrology : JASN 2001, 12: 2051-2059. PMID: 11562403, DOI: 10.1681/ASN.V12102051.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
activity Endocrine Society
Professional OrganizationsMemberDetails2004 - 2024activity American Thyroid Association
Professional OrganizationsMemberDetails2023 - 2024honor Leadership Award as Section Chief
Hospital System AwardHospital of Saint RaphaelDetails07/01/2010United Stateshonor Award for Excellence in Ambulatory Care
Hospital System AwardHospital of Saint RaphaelDetails06/30/2004United Stateshonor Medical Staff President's award for Excellence in Academic Performance
Hospital System AwardHospital of Saint RaphaelDetails06/30/2004United States
Clinical Care
Overview
Olga Sakharova, MD, specializes in endocrinology, diabetes, and metabolism. Her clinical focus is on thyroid disorders, such as thyroid nodules, hyperthyroidism, thyrotoxicosis, and postpartum thyroiditis. She performs various thyroidectomy procedures, including minimally invasive thyroidectomy and transoral endoscopic thyroidectomy vestibular approach (TOETVA).
In addition to her clinical work, Dr. Sakharova's research focuses on diabetes management, adrenal gland disorders, hypertension, hypotension, the endocrine system in critical illness, and renoprotection strategies.
Dr. Sakharova has received multiple awards, including the Leadership Award as section chief, the Award for Excellence in Ambulatory Care, and the Research Fellowship Training Award. She is an assistant professor of medicine at Yale School of Medicine.
Clinical Specialties
Endocrinology
Fact Sheets
Hyperparathyroidism
Learn More on Yale MedicineEndocrine Cancer
Learn More on Yale MedicineDiabetes: Symptoms, Causes, and Treatments
Learn More on Yale MedicineType 2 Diabetes: Symptoms and Treatments
Learn More on Yale Medicine
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileGet In Touch
Contacts
Appointment Number
Mailing Address
Endocrinology
PO Box 208020
New Haven, CT 06520-8020
United States
Administrative Support
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.